KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Inventory (2020 - 2026)

Hims & Hers Health's Inventory history spans 7 years, with the latest figure at $79.1 million for Q1 2026.

  • On a quarterly basis, Inventory rose 3.91% to $79.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $79.1 million, a 3.91% increase, with the full-year FY2025 number at $80.1 million, up 24.37% from a year prior.
  • Inventory hit $79.1 million in Q1 2026 for Hims & Hers Health, down from $80.1 million in the prior quarter.
  • Over the last five years, Inventory for HIMS hit a ceiling of $141.8 million in Q2 2025 and a floor of $12.1 million in Q1 2022.
  • Historically, Inventory has averaged $48.8 million across 5 years, with a median of $29.8 million in 2024.
  • Biggest five-year swings in Inventory: decreased 1.59% in 2023 and later surged 249.36% in 2025.
  • Tracing HIMS's Inventory over 5 years: stood at $21.6 million in 2022, then increased by 4.18% to $22.5 million in 2023, then soared by 186.8% to $64.4 million in 2024, then grew by 24.37% to $80.1 million in 2025, then decreased by 1.32% to $79.1 million in 2026.
  • Business Quant data shows Inventory for HIMS at $79.1 million in Q1 2026, $80.1 million in Q4 2025, and $106.0 million in Q3 2025.